{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:49:22Z","timestamp":1777420162954,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Electronic cigarette (e-cigarette), or vaping, product use-associated lung injury (EVALI) was first identified and reported in 2019, but media coverage and reporting of cases drastically decreased when the COVID-19 pandemic started in early 2020. The syndrome has continued to occur since that time and it is critical that pharmacists are aware of how EVALI presents, and when it should be considered as a potential diagnosis. Inpatient and outpatient pharmacists play a vital role in the treatment of EVALI, and should be knowledgeable of the utility of corticosteroids, even though data are extremely limited. Pharmacists should understand the importance of collecting detailed and accurate information about vaping from patient interviews. Pharmacists also play a leading role in cessation counseling and treatment, selecting medications that can be used to treat nicotine addiction from vaping, and assisting with transitions of care and follow-up.<\/jats:p>","DOI":"10.1177\/10600280231193770","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T01:21:49Z","timestamp":1692667309000},"page":"549-554","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Continues: An Opportunity for Pharmacist Intervention"],"prefix":"10.1177","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5513-6149","authenticated-orcid":false,"given":"Miranda R.","family":"Andrus","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA"},{"name":"Department of Family Medicine, Huntsville Regional Medical Campus, The University of Alabama at Birmingham, Huntsville, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"bibr1-10600280231193770","unstructured":"The Center for Disease Control Prevention. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Published 2020. Accessed June 5, 2023. https:\/\/www.cdc.gov\/tobacco\/basic_information\/e-cigarettes\/severe-lung-disease.html"},{"key":"bibr2-10600280231193770","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6903e2"},{"key":"bibr3-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-020-00772-w"},{"key":"bibr4-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202209-796ST"},{"key":"bibr5-10600280231193770","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6849e1"},{"key":"bibr6-10600280231193770","unstructured":"The Center for Disease Control Prevention For healthcare providers. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Published 2020. Accessed June 5, 2023. https:\/\/www.cdc.gov\/tobacco\/basic_information\/e-cigarettes\/severe-lung-disease\/healthcare-providers\/index.html"},{"key":"bibr7-10600280231193770","unstructured":"Centers for Disease Control and Prevention. ICD-10-CM Official Coding Guidelines: Supplement Coding Encounters Related to E-Cigarette, or Vaping, Product Use. Centers for Disease Control and Prevention. Published 2019. Accessed June 5, 2023. https:\/\/www.cdc.gov\/nchs\/data\/icd\/Vapingcodingguidance2019_10_17_2019.pdf"},{"key":"bibr8-10600280231193770","unstructured":"Gillespie L. Forgotten but not gone: EVALI epidemic continues. WebMD Health News. Published April 17, 2023. Accessed June 5, 2023. https:\/\/www.webmd.com\/lung\/news\/20230425\/epidemic-of-vaping-illness-continues"},{"key":"bibr9-10600280231193770","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6841e3"},{"key":"bibr10-10600280231193770","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6846e2"},{"key":"bibr11-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001160"},{"key":"bibr12-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32679-0"},{"key":"bibr13-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911614"},{"key":"bibr14-10600280231193770","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6836e1"},{"key":"bibr15-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30415-1"},{"key":"bibr16-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.08.012"},{"key":"bibr17-10600280231193770","unstructured":"Help patients break the e-cigarette habit, Pharmacist\u2019s Letter. Published December 2019. Accessed August 2, 2023. https:\/\/www.cdph.ca.gov\/Programs\/CCDPHP\/DCDIC\/CTCB\/CDPH%20Document%20Library\/Community\/CessationServicesandResources\/VapingCessationGuideforPharmacists2019TRC.pdf"},{"key":"bibr18-10600280231193770","volume-title":"Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline","author":"Fiore MC","year":"2008"},{"key":"bibr19-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026642"},{"key":"bibr20-10600280231193770","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1083791"},{"key":"bibr21-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2599"},{"key":"bibr22-10600280231193770","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm685152e1"},{"key":"bibr23-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00415-X"},{"key":"bibr24-10600280231193770","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202201-049OC"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10600280231193770","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10600280231193770","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10600280231193770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:13:18Z","timestamp":1777374798000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10600280231193770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1177\/10600280231193770"],"URL":"https:\/\/doi.org\/10.1177\/10600280231193770","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}